🎉 M&A multiples are live!
Check it out!

Heartseed Valuation Multiples

Discover revenue and EBITDA valuation multiples for Heartseed and similar public comparables like Aroa Biosurgery, Lineage Cell Therapeutics, and Arovella Therapeutics.

Heartseed Overview

About Heartseed

Heartseed Inc is engaged in developing and commercializing iPS cell-derived cardiomyocyte replacement therapy for advanced heart failure.


Founded

2015

HQ

Japan
Employees

n/a

Website

heartseed.jp

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$287M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Heartseed Financials

Heartseed has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Heartseed achieved revenue of $5.8M and an EBITDA of -$5.2M.

Heartseed expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Heartseed valuation multiples based on analyst estimates

Heartseed P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $2.3M $5.8M XXX XXX XXX
Gross Profit $3.3M $2.3M XXX XXX XXX
Gross Margin 145% 39% XXX XXX XXX
EBITDA -$9.6M -$5.2M XXX XXX XXX
EBITDA Margin -420% -89% XXX XXX XXX
Net Profit -$9.4M -$9.8M XXX XXX XXX
Net Margin -410% -169% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Heartseed Stock Performance

As of April 15, 2025, Heartseed's stock price is JPY 2171 (or $14).

Heartseed has current market cap of JPY 48.5B (or $322M), and EV of JPY 43.2B (or $287M).

See Heartseed trading valuation data

Heartseed Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$287M $322M XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Heartseed Valuation Multiples

As of April 15, 2025, Heartseed has market cap of $322M and EV of $287M.

Heartseed's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Heartseed's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Heartseed and 10K+ public comps

Heartseed Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $287M XXX XXX XXX
EV/Revenue 49.5x XXX XXX XXX
EV/EBITDA -55.7x XXX XXX XXX
P/E -59.7x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -30.7x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Heartseed Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Heartseed Valuation Multiples

Heartseed's NTM/LTM revenue growth is n/a

Heartseed's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.

Over next 12 months, Heartseed's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Heartseed's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Heartseed and other 10K+ public comps

Heartseed Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 153% XXX XXX XXX XXX
EBITDA Margin -89% XXX XXX XXX XXX
EBITDA Growth -46% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee n/a XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 219% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Heartseed Public Comps

See public comps and valuation multiples for Regenerative Medicine comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Lineage Cell Therapeutics XXX XXX XXX XXX XXX XXX
Arovella Therapeutics XXX XXX XXX XXX XXX XXX
Aroa Biosurgery XXX XXX XXX XXX XXX XXX
Cynata Therapeutics XXX XXX XXX XXX XXX XXX
Mesoblast XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Heartseed M&A and Investment Activity

Heartseed acquired  XXX companies to date.

Last acquisition by Heartseed was  XXXXXXXX, XXXXX XXXXX XXXXXX . Heartseed acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Heartseed

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Heartseed

When was Heartseed founded? Heartseed was founded in 2015.
Where is Heartseed headquartered? Heartseed is headquartered in Japan.
Is Heartseed publicy listed? Yes, Heartseed is a public company listed on TKS.
What is the stock symbol of Heartseed? Heartseed trades under 219A ticker.
When did Heartseed go public? Heartseed went public in 2024.
Who are competitors of Heartseed? Similar companies to Heartseed include e.g. Lineage Cell Therapeutics, Arovella Therapeutics, Aroa Biosurgery, Cynata Therapeutics.
What is the current market cap of Heartseed? Heartseed's current market cap is $322M
What is the current revenue growth of Heartseed? Heartseed revenue growth between 2023 and 2024 was 153%.
Is Heartseed profitable? Yes, Heartseed is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.